Does the short hairpin RNA driven by polymerase II suppress both wild-type and lamivudine-resistant hepatitis B virus strains?
Silencing by shRNA dramatically inhibited HBV expression and replication regardless of strain type. ShRNA could therefore be a promising treatment for HBV infection.
Our findings suggest that early treatment with IL-6RA after irradiation alone does not protect against radiation-induced lung injury.